These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35765860)

  • 1. Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP).
    Lepley TJ; Wu Z; Root Z; Mountain D; Otto BA; Kelly K; Zhao K
    Int Forum Allergy Rhinol; 2022 Dec; 12(12):1578-1580. PubMed ID: 35765860
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
    Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
    Schneider JS
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):698-9. PubMed ID: 27258602
    [No Abstract]   [Full Text] [Related]  

  • 4. Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.
    Bragança M; Pereira AM; Plácido JL; Amaral L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Jan; 141(1):55-56. PubMed ID: 37591762
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps.
    Mauthe T; Meerwein CM; Ryser FS; Brà Hlmann C; Yalamanoglu A; Steiner UC; Soyka MB
    Rhinology; 2024 Aug; 62(4):496-505. PubMed ID: 38949841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic pulmonary complications of dupilumab in 2 patients with asthma and chronic rhinosinusitis with nasal polyps.
    Frohlich M; Olivenstein R; Cormier M
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):617-619. PubMed ID: 34929373
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
    Fokkens W; Van Der Lans R; Reitsma S
    Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
    [No Abstract]   [Full Text] [Related]  

  • 13. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months.
    van der Lans RJL; Otten JJ; Adriaensen GFJPM; Hoven DR; Benoist LB; Fokkens WJ; Reitsma S
    Allergy; 2023 Oct; 78(10):2684-2697. PubMed ID: 37394895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
    Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T
    BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52.
    Bachert C; Khan AH; Lee SE; Hopkins C; Peters AT; Fokkens W; Praestgaard A; Radwan A; Nash S; Jacob-Nara JA; Deniz Y; Rowe PJ
    Int Forum Allergy Rhinol; 2024 Mar; 14(3):668-678. PubMed ID: 37548085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
    De Corso E; Pasquini E; Trimarchi M; La Mantia I; Pagella F; Ottaviano G; Garzaro M; Pipolo C; Torretta S; Seccia V; Cantone E; Ciofalo A; Lucidi D; Fadda GL; Pafundi PC; Settimi S; Montuori C; Anastasi F; Pagliuca G; Ghidini A; Cavaliere C; Maffei M; Bussu F; Gallo S; Canevari FRM; Paludetti G; Galli J;
    Allergy; 2023 Oct; 78(10):2669-2683. PubMed ID: 37203259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis.
    Peters AT; Wagenmann M; Bernstein JA; Khan AH; Nash S; Jacob-Nara JA; Siddiqui S; Rowe PJ; Deniz Y
    Allergy Asthma Proc; 2023 Jul; 44(4):265-274. PubMed ID: 37480206
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
    Peters AT; Soler ZM; Kern RC; Heffler E; Maspero JF; Crampette L; Fujieda S; Lane AP; Zhang H; Nash S; Khan AH; Siddiqui S; Jacob-Nara JA; Rowe P; Deniz Y
    Clin Exp Allergy; 2022 Sep; 52(9):1105-1109. PubMed ID: 35775319
    [No Abstract]   [Full Text] [Related]  

  • 20. Doxycycline Improves Quality of Life and Anosmia in Chronic Rhinosinusitis With Nasal Polyposis: A Randomized Controlled Trial.
    Nabavi M; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Sabouri S; Moosavian F; Nazari J; Bakrani V; Atashrazm F
    Am J Rhinol Allergy; 2023 Jul; 37(4):384-390. PubMed ID: 36740870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.